#Laurus Labs

[leadertelugunews]

తలసేమియా బాధితులకు ఉచితంగా మెరుగైన వైద్యం - జిల్లా కలెక్టర్ డా. ఎ.మల్లికార్జున

తలసేమియా బాధితులకు ఉచితంగా మెరుగైన వైద్యం – జిల్లా కలెక్టర్ డా. ఎ.మల్లికార్జున

విశాఖపట్నం, సెప్టెంబరు 20: తలసేమియా వ్యాధితో బాదపడుతున్న పిల్లలకు ఉచితంగా మెరుగైన వైద్యం అందించేందుకు తలసేమియా సెంటర్ ను అందుబాటులోకి తీసుకొచ్చామని జిల్లా కలెక్టర్ డాక్టర్ ఎ. మల్లికార్జున తెలిపారు. మంగళవారం ఉదయం పట్టణంలో జిల్లా పరిషత్ జంక్షన్ వద్ద ఉన్న ఇండియన్ రెడ్ క్రాస్ సొసైటి ఆవరణలో లారస్ ల్యాబ్స్ సహకారంతో సుమారు రూ.20 లక్షల వ్యయంతో కొత్తగా నిర్మించిన తలసేమియా సెంటర్ ను లారస్ ల్యాబ్స్ సిఈఓ డా.…

View On WordPress

#A newly built Thalassemia Center at a cost of around Rs.20 lakhs in collaboration with Laurus Labs #District Collector Dr. A. Mallikarjuna #Free better treatment for thalassemia sufferers #Free blood transfusion for 6000 to 10000 anemic children in this center

[bharatlivenewsmedia]

Buy Laurus Labs; target of Rs 700: Motilal Oswal

Buy Laurus Labs; target of Rs 700: Motilal Oswal

Buy Laurus Labs; target of Rs 700: Motilal Oswal Motilal Oswal is bullish on Laurus Labs recommended buy rating on the stock with a target price of Rs 700 in its research report dated April 29, 2022. Motilal Oswal is bullish on Laurus Labs recommended buy rating on the stock with a target price of Rs 700 in its research report dated April 29, 2022. Go to Source

View On WordPress

#700 #buy #economy #labs #laurus #motilal #oswal #target

[prof-oleander]

Hello, My name is Laurus Oleander and I'm a Pokémon Professor from Creekdale, in Arkaion.

My research mostly leans toward studying Regional Forms and Pokémon variants and my Lab is located on the Wildemons Route, close to one of the Wild Areas of my Region.

I'm new to keeping a blog but I was told that is a good way to keep in touch with other people while keeping myself updated and sharing knowledge with others in an easier way.

Honestly, I have no clue on how to make an introduction, so...uh- feel free to ask questions if you'd like.

OOC: useful stuff under the cut

General stuff

Things from Pokémon Universe that are canon here.

Ash isn't canon but a cartoon

About IRL animals

#pokemon headcanons

Arkaion things

Grass Starter

Regional Raichu

Regional Scizor (mentioned)

Other Professors in the region ( 1, 2, ... )

Creekdale (mentioned)

[still work in progress as tumblr broke again the search bar and I can't find stuff in my blog]

#prof-oleander #pokemon professor #pokemon oc #pokemon ask blog #pokemon headcanons #pokemon #pokeblog #pokeaskblog

[priceactiontelugu]

పోస్ట్ మార్కెట్ రిపోర్ట్ HDFC BANK LAURUS LABS TECHM DLF #stocks #telu...

#youtube

[12blogmk]

Laurus: Laurus Labs ties up with IITK for gene therapies | India News

MUMBAI: Hyderabad-based Laurus Labs has signed a memorandum of association with Indian Institute of Technology, Kanpur (IITK) for introducing novel gene therapy assets in India and other markets.According to the agreement, Laurus labs will in-license a few gene therapy assets, and provide research grants for advancing these products through the pre-clinical development, says a company…

View On WordPress

[addictionfinance]

#adani #bank #news

[filmishine]

ChatGPT Was Asked To Choose Between Laurus And Divis Labs. Here's What It Replied.

Divis Labs has also come under sustained attack from bears. (File) It won’t be an understatement to say that ChatGPT has taken the world by storm. Just to put things in perspective, this so-called Artificial Intelligence initiative, is believed to have more than 100 m active monthly users since its launch in December 2022. This is a feat that took TikTok nine months and Instagram two and a half…

View On WordPress

[healthscene]

The revolution in pharmaceutical companies through the influence of contract organizations

The term contract development and manufacturing organization (CDMO) refers to companies that provide comprehensive services and solutions to the pharmaceutical and biotech industries, ranging from drug development to product packaging. Clinical research and development, formulation assistance, a smooth manufacturing process, analytical and regulatory support, and efficient packaging services are just a few of the services provided by these organizations. 

The following are some of the advantages of CDMOs: 

The ability to scale from the drug discovery stage to production at a cheaper cost. 

Expertise, capability, and flexibility in the drug development process and other aspects of drug development.

Allows businesses to benefit from equipment and technology without having to own it. 

The manufacturing process can save roughly 30-35 percent of the entire expenses of medication development.

Because of the CDMOs' dependability, outsourcing partners have become more adaptable in answering specific demands, allowing them to expand their current services, research, and development departments. The pharmaceutical sector faced operational issues as a result of the pandemic, including the capacity to continue supplying needed drugs. At the same time, it created chances for the CDMO industry to play a key role in the COVID-19 therapy and vaccine development process. Pharmaceutical businesses are increasingly looking for outsourcing alternatives to assist manage complexity while decreasing time to market, costs, and risk as the pressure to develop and provide pharmaceuticals to satisfy ever-increasing worldwide demand grows.

The segmentation of pharmaceutical services is broadly categorized into three categories which are Contract Research Organizations (CROs) services that provide drug discovery and development support to pharmaceutical companies, Contract Development Manufacturing Organizations (CDMOs) services that include drug development, API production, and formulation requirements, and Contract Packaging Organizations (CPOs) services that provide end-to-end services and include primary, secondary, and tertiary packaging. 

In the development process, drug developers are collaborating with CDMOs and CROs to help overcome crucial difficulties and achieve higher efficiency across the drug development industry. According to DeleInsight, the global biologic drug substance manufacturing market was worth USD 303.95 billion in 2020 and is expected to increase at a CAGR of 9.59 percent from 2021 to 2026. Better therapeutic effects of biologics when compared to small molecules, increasing demand for biologic drugs in various indications, demand for COVID-19 vaccines, growing capital investment in biologics manufacturing, and surging interest in the development of targeted medicines in the form of gene therapy for rising cancer and rare indications are some of the major factors driving the growth of the global biologics drug substance manufacturing market.

Top CDMO companies operating in the market include Cambrex Corporation, CARBOGEN AMCIS, CordenPharma, Dipharma Francis Srl, Flamma Group, Formosa Laboratories Inc, Frontage Laboratories Inc, Fujifilm Diosynth Biotechnologies, Hovione, Jubilant Biosys Limited, Laurus Labs, Laviana Pharma Co, Ltd, LEBSA, Lonza Group AG, Neuland Laboratories Ltd, NextPharma GmbH, Northway Biotech, Novasep, Syngene International Limited, Wavelength Pharmaceuticals, and Windlas Biotech, among others.

CDMOs are adopting continuous or flexible manufacturing methods, which have several key advantages over batch manufacturing, including a 50-70% workforce reduction, a 15-30% reduction in production costs, a 50% reduction in product difference, a 40% reduction in energy usage, a 50-70% reduction in footprint requirement, and accelerated scale-up. CM minimizes API waste, production time, improves scale-up economies, enables stronger quality assurance, and adapts effectively to changes in market demand, all of which will help the market develop at a healthy rate throughout the projection period. As a result, CDMOs are proving to be extremely beneficial to the biotechnology and pharmaceutical industries, as they provide prospective capabilities and cost savings over in-house manufacturing.

DelveInsght’s Competitive Intelligence Service includes a multidimensional coverage, helping to keep track of competitors and gain traction in the dynamic market by overcoming the challenges and expediting business growth through a strategic and tactical approach.

To know more about our Consulting Services, Click here: Healthcare Consulting Services

#contract development and manufacturing organization #contract development and manufacturing organization Market #contract development and manufacturing organization Market Size #contract development and manufacturing organization Epidemiology #contract development and manufacturing organization Pipeline #contract development and manufacturing organization Symptoms #contract development and manufacturing organization Diagnosis #contract development and manufacturing organization Therapies #contract development and manufacturing organization Treatment #contract development and manufacturing organization Treatment Landscape #contract development and manufacturing organization Upcoming Trends #contract development and manufacturing organization Market Forecast #contract development and manufacturing organization Emerging Therapies #contract development and manufacturing organization Market Trends

[online-journalist]

Dr.Anurag Batra-Fastest Growing Companies 2022: Deep-Dive Into The Financials Of The Listed Companies

One of the youngest media moguls from India, Dr. Anurag batra is a serial entrepreneur and a mentor to many successful entrepreneurs. He is a man of many talents and someone who adorns many hats. Anurag Batra is also an author, an angel investor and a TV show host and the founder of the iconic exchange4media group and Chairman BW Businessworld group. BW Businessworld presents the 2022 edition of the Fastest Growing Companies study after a deep-dive into the financials of the listed companies followed by intelligent number crunching.

Dr. Anurag batra, Editor-in-Chief, e4m & BW Businessworld presents his views on this study. “Sustaining a steady growth momentum for listed companies is in itself a creditable performance. We at BW Businessworld are happy to present our annual special issue capturing the Fastest Growing Companies, based on an in-depth study and after a deep-dive into the financials of listed companies followed by intelligent number crunching”, he said.

The research was carried out by our knowledge partner, TechSci Research. The period under review are the five financial years between 2017–18 and 2021–22. The list is based on a study of revenue and profitability data for these last five financial years. Companies in sectors like steel, cement, energy, chemicals, packaging, telecommunication, biotech and healthcare have emerged as the fastest growing in each of the financial categories.

Watch More:

“In the ‘Super Heavyweight’ category, in which companies had net sales of Rs 50,000 crore and above, the companies on the top rung include JSW Steel, UltraTech Cement, Grasim Industries, Tata Steel and Bharti Airtel. In the ‘Heavyweight’ segment, where net sales are between Rs 10,000 crore and Rs 49,999 crore, Deepak Nitrite, AGC Networks, Godawari Power & Ispat and J.K. Lakshmi Cement were in the forefront”, Anurag batra said.

The ‘Middleweight’ category had companies with revenue between Rs 1,000 crore and Rs 4,999 crore. It had Apollo Healthcare, Indus Towers, Gokul Agro Resources, Gujarat Gas and APL Apollo Tubes showing the fastest rate of growth. In the ‘Welterweight’ category of companies with net sales between Rs 1,000 crore and Rs 4,999 crore, Kirloskar Ferrous, Laurus Labs, TinPlate Company, Narayana Health and Cosmo First bagged the top ranks. Several profiled companies clocked record growth numbers in FY2022 while maintaining a healthy growth rate in the previous two fiscal years despite the Covid-induced challenges, Anurag batra concluded.

#Anurag Batra #Dr.Anurag batra #Annurag Batra #Anurag Batra BW #Anurag Batra Businessworld #Youtube

[anuragbatra]

Anurag Batra and BW Businessworld Presents the 2022 Edition of the Fastest Growing Companies Study

Anurag Batra BW is a serial entrepreneur, media mogul, a journalist and an eternal optimist rolled into one. He is a B. Tech in Computer Sciences, a degree, which he acquired before joining Management Development Institute MDI, one of India's leading Business School. He is a first-generation entrepreneur and after acquiring the iconic business media and magazine brand BW Businessworld, a 36-year strong media brand as well as most respected business publication in the country.

Anurag Batra also founded the exchange4media group. Annurag Batra is also appointed by Government of India as the Chairman of an industry committee formed to come up with a vocational training framework for the media, communication and entertainment industry. BW Businessworld presents the 2022 edition of the Fastest Growing Companies study after a deep-dive into the financials of the listed companies followed by intelligent number crunching. Anurag Batra in his latest article reflects on the Growth Mantra of these companies.

According to Mr. Anurag Batra, sustaining a steady growth momentum for listed companies is in itself a creditable performance. “We at BW Businessworld are happy to present our annual special issue capturing the Fastest Growing Companies, based on an in-depth study and after a deep-dive into the financials of listed companies followed by intelligent number crunching”, Anurag Batra says in his latest article. The research was carried out by the knowledge partner of BW Businessworld, TechSci Research.

The period under review are the five financial years between 2017-18 and   2021-22. The list is based on a study of revenue and profitability data for these last five financial years. As per Mr. Anurag Batra’s view, companies in sectors like steel, cement, energy, chemicals, packaging, telecommunication, biotech and healthcare have emerged as the fastest growing in each of the financial categories. In the ‘Super Heavyweight’ category, in which companies had net sales of Rs 50,000 crore and above, the companies on the top rung include JSW Steel, UltraTech Cement, Grasim Industries, Tata Steel and Bharti Airtel.

In the ‘Heavyweight’ segment, where net sales are between Rs 10,000 crore and Rs 49,999 crore, Deepak Nitrite, AGC Networks, Godawari Power & Ispat and J.K. Lakshmi Cement were in the forefront, Anurag Batra points out. “The 'Middleweight' category had companies with revenue between Rs 1,000 crore and Rs 4,999 crore. It had Apollo Healthcare, Indus Towers, Gokul Agro Resources, Gujarat Gas and APL Apollo Tubes showing the fastest rate of growth”, said Mr. Batra.

In the 'Welterweight’ category of companies with net sales between Rs 1,000 crore and Rs 4,999 crore, Kirloskar Ferrous, Laurus Labs, TinPlate Company, Narayana Health and Cosmo First bagged the top ranks. Anurag Batra also highlighted that several profiled companies clocked record growth numbers in FY2022 while maintaining a healthy growth rate in the previous two fiscal years despite the Covid-induced challenges.

In another special feature, Anurag Batra Businessworld also brings to you reports on how the government, public and private enterprises are preparing to meet India’s Net Zero 2070 target to usher in a “green economy”. Experts including Anurag Batra, says that the Net Zero emissions goal could actually bring tangible benefits not just to the environment, but also to the Indian economy, by boosting the growth momentum by about 4.7 per cent by 2036, and 3.5 per cent by 2060.

Both public and private enterprises are investing in technology to reduce their carbon footprint in manufacturing, logistics and other aspects of the supply chain. Anurag Batra also explains how crucial the switch to electric vehicles (EV) is and the views of industry leaders on what the automotive industry is doing to adopt the EV 30@30 goal.

#Anurag Batra Businessworld #Anurag Batra BW #Anurag Batra

[thegoldenstar]

Anurag Batra Businessworld Presents the 2022 Edition of the Fastest Growing Companies Study

Anurag Batra BW is a serial entrepreneur, media mogul, a journalist and an eternal optimist rolled into one. He is a B. Tech in Computer Sciences, a degree, which he acquired before joining Management Development Institute MDI, one of India's leading Business School. He is a first-generation entrepreneur and after acquiring the iconic business media and magazine brand BW Businessworld, a 36-year strong media brand as well as most respected business publication in the country.

Anurag Batra also founded the exchange4media group. Annurag Batra is also appointed by Government of India as the Chairman of an industry committee formed to come up with a vocational training framework for the media, communication and entertainment industry. BW Businessworld presents the 2022 edition of the Fastest Growing Companies study after a deep-dive into the financials of the listed companies followed by intelligent number crunching. Anurag Batra in his latest article reflects on the Growth Mantra of these companies.

According to Mr. Anurag Batra, sustaining a steady growth momentum for listed companies is in itself a creditable performance. “We at BW Businessworld are happy to present our annual special issue capturing the Fastest Growing Companies, based on an in-depth study and after a deep-dive into the financials of listed companies followed by intelligent number crunching”, Anurag Batra says in his latest article. The research was carried out by the knowledge partner of BW Businessworld, TechSci Research.

The period under review are the five financial years between 2017-18 and   2021-22. The list is based on a study of revenue and profitability data for these last five financial years. As per Mr. Anurag Batra’s view, companies in sectors like steel, cement, energy, chemicals, packaging, telecommunication, biotech and healthcare have emerged as the fastest growing in each of the financial categories. In the ‘Super Heavyweight’ category, in which companies had net sales of Rs 50,000 crore and above, the companies on the top rung include JSW Steel, UltraTech Cement, Grasim Industries, Tata Steel and Bharti Airtel.

In the ‘Heavyweight’ segment, where net sales are between Rs 10,000 crore and Rs 49,999 crore, Deepak Nitrite, AGC Networks, Godawari Power & Ispat and J.K. Lakshmi Cement were in the forefront, Anurag Batra points out. “The 'Middleweight' category had companies with revenue between Rs 1,000 crore and Rs 4,999 crore. It had Apollo Healthcare, Indus Towers, Gokul Agro Resources, Gujarat Gas and APL Apollo Tubes showing the fastest rate of growth”, said Mr. Batra.

In the 'Welterweight’ category of companies with net sales between Rs 1,000 crore and Rs 4,999 crore, Kirloskar Ferrous, Laurus Labs, TinPlate Company, Narayana Health and Cosmo First bagged the top ranks. Anurag Batra also highlighted that several profiled companies clocked record growth numbers in FY2022 while maintaining a healthy growth rate in the previous two fiscal years despite the Covid-induced challenges.

In another special feature, Anurag Batra Businessworld also brings to you reports on how the government, public and private enterprises are preparing to meet India’s Net Zero 2070 target to usher in a “green economy”. Experts including Anurag Batra, says that the Net Zero emissions goal could actually bring tangible benefits not just to the environment, but also to the Indian economy, by boosting the growth momentum by about 4.7 per cent by 2036, and 3.5 per cent by 2060.

Both public and private enterprises are investing in technology to reduce their carbon footprint in manufacturing, logistics and other aspects of the supply chain. Anurag Batra also explains how crucial the switch to electric vehicles (EV) is and the views of industry leaders on what the automotive industry is doing to adopt the EV 30@30 goal.

#Anurag batra #Anurag Batra Businessworld #Anurag Batra BW

[demataccount]

Get Latest Updates on Laurus Labs Share Online at 5paisa

Check Laurus lab share price today with delivery and volume of Nse and Bse, and also check the key statistics. Get more information of laurus labs at 5paisa now!

https://www.5paisa.com/stocks/LAURUSLABS

[znewstech]

Laurus Labs Q1 net improves marginally

Laurus Labs Q1 net improves marginally

Drugmaker Laurus Labs said consolidated net profit rose close to 5% to ₹252.54 crore for the quarter ended June 2022, amid significant pricing pressure on key antiretroviral (ARV) APIs and the formulation business. The growth on a 20% increase in revenue from operations to ₹1,540.69 crore (₹1,284.35 crore a year earlier). The performance reflects the company’s efforts towards strengthening and…

View On WordPress

[digitaltrand]

Stock Talk| Why Bharat Forge, IndusInd, Laurus Labs Fut are a short-term Sell

Stock Talk| Why Bharat Forge, IndusInd, Laurus Labs Fut are a short-term Sell

IndusInd Bank is on the verge of a major breakdown from its previous multiple support zones. What is worrying is that the stock has seen rising volumes in the current downtrend, confirming the weakness. Kunal Shah June 17, 2022 / 08:09 AM IST The benchmark Nifty50 has witnessed a major breakdown on June 16 after the FOMC outcome, with the index falling near the next level of 15,300. Kunal Shah,…

View On WordPress